Bryan, Garnier & Co Stock Recommendations and Price Targets

This is a list of recent ratings by Bryan, Garnier & Co.

Date	Company Name	Action	Current Price	Price Target	Rating
11/7/2024	NKLAQ Nikola	Downgrade	$0.00		Buy ➝ Neutral
5/16/2024	NKLAQ Nikola	Initiated Coverage	$0.00	$30.00	Buy
9/14/2023	MLTX MoonLake Immunotherapeutics	Downgrade	$15.00		Buy ➝ Neutral
5/5/2023	TVTX Travere Therapeutics	Upgrade	$35.00		Sell ➝ Neutral
3/24/2023	ADAP Adaptimmune Therapeutics	Initiated Coverage	$0.00	$3.60	Buy
3/24/2023	IMTX Immatics	Initiated Coverage	$12.00	$16.00	Buy
3/24/2023	IMCR Immunocore	Initiated Coverage	$40.00	$16.00	Buy
3/17/2023	CLLS Cellectis	Initiated Coverage	$5.00	$6.00	Buy
3/17/2023	AUTL Autolus Therapeutics	Initiated Coverage	$2.00	$5.00	Buy
3/17/2023	CRSP CRISPR Therapeutics	Initiated Coverage	$58.00	$70.00	Buy
2/2/2023	MLTX MoonLake Immunotherapeutics	Initiated Coverage	$15.00	$22.00	Buy
12/14/2022	HXGBY Hexagon	Initiated Coverage	SEK 12	SEK 100	Sell
12/14/2022	NEMTF Nemetschek	Upgrade	€129.00	€60.00	Neutral ➝ Buy
12/14/2022	SAP SAP	Set Price Target	€209.00	€130.00